Status:
UNKNOWN
Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients
Lead Sponsor:
Samsung Medical Center
Conditions:
Dry Eye
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
To investigate the clinical outcome of Lipiflow treatment prior to cataract surgery in patients with meibomian gland dysfunction and dry eye disease
Eligibility Criteria
Inclusion
- Patients older than 21, who will get catarct surgeyr
- Patients whose visual acuity anticipated better than 20/25 after surgery
- Patients with informed consent
- Patients with meibomian gland dysfunction
Exclusion
- ocular injury, active injection
- uncontrolled systemic disease
- Contact lens wear within 1 month
- Allergic to fluorescein sodium or topical anesthetics
- ocular surgery or trauma within 6 months
- disorder of lid anatomy
- other reason for decreased vision other than cataract
- anticipated visual acuity less than 20/25
- Patients less than 20 years.
Key Trial Info
Start Date :
March 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04457999
Start Date
March 20 2020
End Date
July 30 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea